Integrated BioPharma Past Earnings Performance
Past criteria checks 0/6
Integrated BioPharma's earnings have been declining at an average annual rate of -15.1%, while the Personal Products industry saw earnings growing at 14.8% annually. Revenues have been declining at an average rate of 0.09% per year.
Key information
-15.1%
Earnings growth rate
-15.6%
EPS growth rate
Personal Products Industry Growth | 20.9% |
Revenue growth rate | -0.09% |
Return on equity | -0.6% |
Net Margin | -0.2% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Integrated BioPharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 51 | 0 | 4 | 0 |
31 Dec 23 | 51 | 0 | 4 | 0 |
30 Sep 23 | 51 | 0 | 4 | 0 |
30 Jun 23 | 51 | 0 | 4 | 0 |
31 Mar 23 | 51 | 1 | 4 | 0 |
31 Dec 22 | 53 | 2 | 4 | 0 |
30 Sep 22 | 56 | 3 | 4 | 0 |
30 Jun 22 | 56 | 4 | 4 | 0 |
31 Mar 22 | 60 | 7 | 4 | 0 |
31 Dec 21 | 61 | 7 | 4 | 0 |
30 Sep 21 | 61 | 7 | 4 | 0 |
30 Jun 21 | 64 | 8 | 4 | 0 |
31 Mar 21 | 60 | 5 | 4 | 0 |
31 Dec 20 | 57 | 5 | 4 | 0 |
30 Sep 20 | 57 | 5 | 3 | 0 |
30 Jun 20 | 53 | 4 | 3 | 0 |
31 Mar 20 | 53 | 3 | 4 | 0 |
31 Dec 19 | 53 | 3 | 4 | 0 |
30 Sep 19 | 51 | 2 | 4 | 0 |
30 Jun 19 | 50 | 2 | 4 | 0 |
31 Mar 19 | 49 | 2 | 3 | 0 |
31 Dec 18 | 45 | 2 | 3 | 0 |
30 Sep 18 | 44 | 1 | 3 | 0 |
30 Jun 18 | 44 | 1 | 3 | 0 |
31 Mar 18 | 42 | 1 | 3 | 0 |
31 Dec 17 | 42 | 1 | 3 | 0 |
30 Sep 17 | 44 | 2 | 3 | 0 |
30 Jun 17 | 47 | 2 | 3 | 0 |
31 Mar 17 | 47 | 2 | 3 | 0 |
31 Dec 16 | 47 | 1 | 3 | 0 |
30 Sep 16 | 45 | 1 | 3 | 0 |
30 Jun 16 | 42 | 1 | 3 | 0 |
31 Mar 16 | 40 | 0 | 3 | 0 |
31 Dec 15 | 38 | 0 | 3 | 0 |
30 Sep 15 | 38 | 1 | 3 | 0 |
30 Jun 15 | 37 | 1 | 3 | 0 |
31 Mar 15 | 37 | 1 | 3 | 0 |
31 Dec 14 | 35 | 0 | 3 | 0 |
30 Sep 14 | 33 | 0 | 3 | 0 |
30 Jun 14 | 34 | 0 | 3 | 0 |
31 Mar 14 | 35 | 1 | 4 | 0 |
31 Dec 13 | 36 | 1 | 4 | 0 |
30 Sep 13 | 34 | 1 | 4 | 0 |
30 Jun 13 | 34 | 0 | 4 | 0 |
Quality Earnings: INBP is currently unprofitable.
Growing Profit Margin: INBP is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: INBP is unprofitable, and losses have increased over the past 5 years at a rate of 15.1% per year.
Accelerating Growth: Unable to compare INBP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: INBP is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (6.9%).
Return on Equity
High ROE: INBP has a negative Return on Equity (-0.61%), as it is currently unprofitable.